Literature DB >> 20865634

Pathophysiology of typical hemolytic uremic syndrome.

Diana Karpman1, Lisa Sartz, Sally Johnson.   

Abstract

The typical form of hemolytic uremic syndrome (HUS) is associated with enterohemorrhagic ESCHERICHIA COLI (EHEC) infection. The disease process is initiated and perpetuated by interactions between the pathogen or its virulence factors and host cells, as well as the host response. During EHEC-associated HUS, alterations occurring at the intestinal mucosal barrier and in the circulation, as well as on endothelial cells and other target-organ cells, lead to cell activation and/or cytotoxicity, and trigger a prothrombotic state. This review summarizes current knowledge regarding the interactions of the pathogen and its virulence factors with cells in the intestine, bloodstream, kidney, and brain. Mechanisms of bacterial colonization, toxin circulation, and induction of target organ damage are discussed. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865634     DOI: 10.1055/s-0030-1262879

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  16 in total

1.  Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL.

Authors:  Ievgeniia Burlaka; Xiao Li Liu; Johan Rebetz; Ida Arvidsson; Liping Yang; Hjalmar Brismar; Diana Karpman; Anita Aperia
Journal:  J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 10.121

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 3.  The role of the antimicrobial peptide cathelicidin in renal diseases.

Authors:  Milan Chromek
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

Review 4.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

Review 6.  Enterohemorrhagic Escherichia coli and a Fresh View on Shiga Toxin-Binding Glycosphingolipids of Primary Human Kidney and Colon Epithelial Cells and Their Toxin Susceptibility.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

7.  Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage.

Authors:  Verónica Inés Landoni; Jose R Pittaluga; Agostina Carestia; Luis Alejandro Castillo; Marcelo de Campos Nebel; Daiana Martire-Greco; Federico Birnberg-Weiss; Mirta Schattner; Pablo Schierloh; Gabriela C Fernández
Journal:  Front Cell Infect Microbiol       Date:  2022-06-23       Impact factor: 6.073

Review 8.  Thrombotic microangiopathy and associated renal disorders.

Authors:  Thomas Barbour; Sally Johnson; Solomon Cohney; Peter Hughes
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

9.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome.

Authors:  Johan M Lorenzen; Jan Menne; Bernhard M W Schmidt; Mascha Schmidt; Filippo Martino; Robert Dietrich; Senguel Samiri; Hans Worthmann; Meike Heeren; Karin Weissenborn; Hermann Haller; Mario Schiffer; Jan T Kielstein; Thomas Thum
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.